Testing effectiveness (Phase 2)Study completedNCT02023866
What this trial is testing
Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
Who this might be right for
Inherited Mitochondrial Disease, Including Leigh Syndrome
Amgen 36